Evidence 1
Activity
Activity
<5% Hemolysis
Toxicity
125 µg/mL
Hemolytic
Cytotoxic
<5% Hemolysis | 125 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Structure-guided de novo design of alpha-helical antimicrobial peptide with enhanced specificity | Pure Appl Chem | 2010